Quest to sell Thermo Fisher's peanut allergy diagnostic

Thermo Fisher Scientific ($TMO) has inked a distribution deal with Quest Diagnostics ($DGX) for its peanut allergy tests. Neither side is disclosing financial terms, but the non-exclusive deal calls for Quest to market the company's ImmunoCAP Peanut Component blood test to physicians across the country. The arrangement also allows both companies to co-market ImmunoCAP test services offered at Quest clinical laboratories. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.